U.S. adults aged 18-26 who received one or more doses of the HPV vaccine 2013-2018
Roughly 40 percent of U.S. adults aged between 18 and 26 years had received one or more doses of the human papillomavirus (HPV) vaccine, versus approximately 22 percent in 2013. The statistic illustrates the share of adults aged 18-26 in the U.S. who had received one or more doses of the human papillomavirus vaccine between 2013 and 2018.